Location History:
- Tokyo, JP (2014 - 2018)
- Ibaraki, JP (2018)
Company Filing History:
8 out of 26 
3 out of 35 
1 out of 9 Years Active: 2014-2018
Title: Katsuyuki Mitomo: Innovator in Antibody and Gene Therapy Technologies
Introduction
Katsuyuki Mitomo is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the fields of antibody development and gene therapy. With a total of nine patents to his name, Mitomo has made strides in addressing critical health challenges, particularly in cancer treatment and genetic respiratory diseases.
Latest Patents
Among his latest patents is an innovative antibody that specifically reacts with the human integrin A6B4 complex. This invention aims to inhibit the adhesion of cancer cells to the bone marrow niche, thereby enhancing the efficacy of anticancer agents against resistant strains. Another notable patent involves a method for gene transfer into airway epithelial stem cells using lentiviral vectors pseudotyped with RNA or DNA virus spike proteins. This technique holds promise for gene therapy in treating genetic respiratory diseases, such as cystic fibrosis, by enabling the production of essential proteins in targeted respiratory organs.
Career Highlights
Katsuyuki Mitomo has worked with notable organizations, including Perseus Proteomics Inc. and the University of Miyazaki. His work in these institutions has allowed him to collaborate on groundbreaking research and development projects that push the boundaries of medical science.
Collaborations
Mitomo has collaborated with esteemed colleagues, including Fumiko Nomura and Katsushi Kouda, contributing to a rich exchange of ideas and expertise in his field.
Conclusion
Katsuyuki Mitomo's innovative work in antibody and gene therapy technologies showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of cancer and genetic diseases, making him a noteworthy figure in the realm of modern inventions.